Showing results (11-20 of 4,844) with videos related to
Sort By:
Pageof 485
Immunological Investigations|March 1, 1993
Immunopriming of tumor infiltrating lymphocytes with neoadjuvant cyclophosphamideP Guinan, M Shaw, M RubensteinUrological Research|January 1, 1986
Histopathology of BCG and thiotepa treated bladdersP Guinan, M Shaw, V RayMedical Oncology (Northwood, London, England)|February 19, 1998
Lack of toxicity associated with the systemic administration of antisense oligonucleotides for treatment of rats bearing LNCaP prostate tumorsM Rubenstein, Y Mirochnik, V Ray, et al.Journal of Surgical Oncology|July 1, 1996
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude miceM Rubenstein, Y Mirochnik, P Chou, et al.Medical Oncology (Northwood, London, England)|March 1, 1997
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivationM Rubenstein, P Chou, Y Mirochnik, et al.Methods and Findings in Experimental and Clinical Pharmacology|March 26, 1999
Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotidesM Rubenstein, Y Mirochnik, P Chou, et al.Journal of the National Medical Association|October 1, 1995
The impact of transrectal ultrasound on stage migration in a predominantly African-American populationR Saffrin, C Phillips, P GuinanClinical Physiology and Biochemistry|January 1, 1990
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapyM Johnson, M Shaw, M Rubenstein, et al.Urological Research|January 1, 1987
Lymphocyte subsets in urologic cancer patientsM Shaw, P Ray, M Rubenstein, et al.Medical Oncology (Northwood, London, England)|February 19, 1998
The effect of androgen deprivation on malignant and benign prostate tissueP Guinan, D Didomenico, J Brown, et al.Pageof 485